Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Look at Three Biotech Movers
Motley Fool
Saturday, January 26, 2013 - 11:43am
tags:
Sarepta Therapeutics, Celsion, Threshold Pharmaceuticals
Biogen Idec Third Quarter Earnings Sneak Peek
Wall Street Cheat Street
Saturday, January 26, 2013 - 11:42am
tags:
Biogen Idec, earnings
Pfizer's Success Plan: Streamline Business And Introduce New Drugs
Seeking Alpha
Friday, January 25, 2013 - 11:59am
tags:
Pfizer, Novartis
A.P. Pharma: PDUFA Date On APF530 Looms And I Am A Buyer
Seeking Alpha
Friday, January 25, 2013 - 11:58am
tags:
AP Pharma, APF530
Eli Lilly & Co Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, January 25, 2013 - 11:57am
tags:
Eli Lilly, earnings
FDA OKs over-the-counter version of Merck overactive bladder drug
Reuters
Friday, January 25, 2013 - 11:57am
tags:
FDA, Merck, overactive bladder, Oxytrol
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Friday, January 25, 2013 - 11:05am
tags:
CETP inhibitors, Merck, Anacetrapib, Torcetrapib, Pfizer, Roche, dalceptrapib
Should Gilead's quad pill get an exclusivity extension from FDA?
Fierce Pharma
Friday, January 25, 2013 - 10:44am
tags:
Quad, Gilead, FDA, HIV
Novartis Board Was Shocked by Vasella’s Decision to Leave
Bloomberg
Friday, January 25, 2013 - 10:43am
tags:
Novartis, Daniel Vasella
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Friday, January 25, 2013 - 10:39am
tags:
Vivus, Theravance, Roche, MAP Pharmaceuticals, M&A, Immunogen, GSK, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan
Novartis Under U.S. Investigation for Tekturna Marketing
Bloomberg
Friday, January 25, 2013 - 10:13am
tags:
Novartis, Tekturna
It's official: Watson changes name to Actavis
Drugstore News
Friday, January 25, 2013 - 10:12am
tags:
Actavis, Watson Pharmaceuticals
Novartis CEO tempers talk of Roche stake sale
Yahoo/Reuters
Friday, January 25, 2013 - 10:11am
tags:
Novartis, Roche, M&A, Joe Jimenez
Geron Corporation's Recent Catalysts
Seeking Alpha
Friday, January 25, 2013 - 10:09am
tags:
Geron
Boehringer’s Lung Drug’s Benefits Questioned
Bloomberg
Friday, January 25, 2013 - 10:08am
tags:
Boehringer Ingelheim, olodaterol, COPD
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Friday, January 25, 2013 - 8:15am
tags:
Allergan, Keryx, MAP Pharmaceuticals, Threshold Pharmaceuticals
Former shareholder sues NuVasive for $660k in missed milestones payments
Mass Device
Thursday, January 24, 2013 - 10:24pm
tags:
NuVasive, Milestone, legal, lawsuit, devices
Medtronic lands new EU indications for Complete SE stent
Mass Device
Thursday, January 24, 2013 - 10:23pm
tags:
Medtronic, EU, stent, regulatory, devices
Bausch + Lomb lands Class I recall status after broken syringes harm patients
Mass Device
Thursday, January 24, 2013 - 10:23pm
tags:
recall, regulatory, devices, Syringe, patients
FDA abandons off-label marketing protection ruling
Mass Device
Thursday, January 24, 2013 - 10:22pm
tags:
FDA, regulatory, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.